Botryoid rhabdomyosarcoma
MONDO:0002578A morphologic variant of embryonal rhabdomyosarcoma arising from organs with a mucosal epithelial surface. It is characterized by the formation of a cambium layer in the affected tissue and polypoid nodules within an abundant myxoid stroma.
Also known as: botryoid sarcoma, botryoid sarcoma (morphologic abnormality), botryoid-type embryonal rhabdomyosarcoma, sarcoma botryoides
2817 clinical trials for this condition and its sub-types, 2 tagged with Botryoid rhabdomyosarcoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Botryoid rhabdomyosarcoma
-
Adult botryoid rhabdomyosarcoma 0 trials
1 sub-type
-
2 sub-types
-
Childhood botryoid rhabdomyosarcoma 0 trials
2 sub-types
-
Could adding temsirolimus boost chemo for childhood muscle cancer?
Disease control OngoingThis phase 3 trial tests whether adding the drug temsirolimus to standard chemotherapy helps children and young adults with intermediate-risk rhabdomyosarcoma, a type of muscle cancer. About 325 participants receive either standard chemo or standard chemo plus temsirolimus. The s…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug cocktail shows promise against aggressive childhood cancer
Disease control OngoingThis study tests whether adding a drug called vinorelbine to standard chemotherapy can better control high-risk rhabdomyosarcoma, a rare and aggressive muscle cancer in children and young adults. About 118 participants will receive either the standard treatment or the new combina…
Phase 3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC